Art

J-GLOBAL ID：201802270911376972   Reference number：18A0268912

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology

非ホジキンリンパ腫のためのイットリウム-90イブリツモマブチウキセタンプラス高用量BCNU,エトポシド,シタラビンおよびメルファランの第II相試験:組織学の役割【Powered by NICT】

Author (13)： Krishnan Amrita Y. (Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, California) ,  Krishnan Amrita Y. (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California) ,  Palmer Joycelynne (Department of Information Sciences, City of Hope, Duarte, California) ,  Nademanee Auayporn P. (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California) ,  Chen Robert (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California) ,  Popplewell Leslie L. (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California) ,  Tsai Ni-Chun (Department of Information Sciences, City of Hope, Duarte, California) ,  Sanchez James F. (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California) ,  Simpson Jennifer (Clinical Trials Office, City of Hope, Duarte, California) ,  Spielberger Ricardo (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California) ,  Spielberger Ricardo (Southern California Kaiser Permanente Bone Marrow Transplant Program, Los Angeles, California) ,  Yamauchi Dave (Department of Diagnostic Radiology, City of Hope, Duarte, California) ,  Forman Stephen J. (Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California)
Material： Biology of Blood and Marrow Transplantation  (Biol Blood Marrow Transplant)
Volume： 23  Issue： 6  Page： 922-929  Publication year： 2017 
JST Material Number： W1625A  ISSN： 1083-8791  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Standard-dose ⁹⁰ytt...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0268912&from=J-GLOBAL&jstjournalNo=W1625A") }}

Thesaurus term： pretreatment ,  patient ,  *non-Hodgkin's lymphoma ,  therapy ,  Safety ,  *phase 2 study ,  tolerability ,  *high dosage ,  amino acid ,  aromatic amine ,  organochlorine compound ,  diamine ,  primary amine ,  tertiary amine ,  nitrogen heterocyclic compound ,  pyrimidine nucleoside ,  urea compound ,  furanoside ,  alicyclic compound ,  lactone ,  enzyme inhibitor ,  phenolic compound ,  glycoside (except carbohydrate) ,  olefin compound ,  pyranoside ,  glucoside ,  phenol ether ,  polynuclear aromatic compound
Semi thesaurus term： 全生存率 ,  びまん性B細胞性大細胞型リンパ腫 ,  自家造血幹細胞移植 ,  *イブリツモマブチウキセタン , 【Automatic Indexing@JST】

Author keywords (5)： Zevalin ,  BEAM ,  ⁹⁰yttrium-ibritumomab tiuxetan ,  Radioimmunotherapy ,  Autologous stem cell transplantation

JST classification (2)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Substance index (3)： Melphalan ,  Cytarabine ,  Etoposide

Terms in the title (11)： 非ホジキンリンパ腫 ,  イットリウム ,  イブリツモマブチウキセタン ,  高用量 ,  BCNU ,  エトポシド ,  シタラビン ,  メルファラン ,  第II相試験 ,  組織学 ,  役割